A Randomized, Double-blind, Placebo-controlled, Parallel Group Trial Assessing the Rate of Decline of Lung Function With Tiotropium 18 mcg Inhalation Capsule Once Daily in Patients With Chronic Obstructive Pulmonary Disease (COPD).
A Randomized, Double-blind, Placebo-controlled, Parallel Group Trial Assessing the Rate of Decline of Lung Function With Tiotropium 18 mcg Inhalation Capsule Once Daily in Patients With Chronic Obstructive Pulmonary Disease (COPD).
The primary objective of this trial is to determine whether daily treatment with tiotropium (Spiriva®, Bromuro de Tiotropio®) inhalation capsule via HandiHaler® reduces the rate of decline in lung function over time in patients with COPD.
Inclusion Criteria:
Exclusion Criteria:
Escondito, California, United States
Bidderford, Maine, United States
Elizabath City, North Carolina, United States
Capital Federal, Argentina
Capital Federal, Argentina
Capital Federal, Argentina
Capital Federal, Argentina
Capital Federal, Argentina
Capital Federal, Argentina
Capital Federal, Argentina
Parque Velez Sarlfield, Argentina
Luxembourg, Belgium
Middelheim, Belgium
Florianópolis - SC, Brazil
Juiz de Fora - MG, Brazil
Porto Alegre - RS, Brazil
Porto Alegre - RS, Brazil
Porto Alegre - RS, Brazil
Porto Alegre - RS, Brazil
Rio de Janeiro - RJ, Brazil
Rio de Janeiro - RJ, Brazil
Salvador - BA, Brazil
Santo André - SP, Brazil
São Paulo - SP, Brazil
São Paulo - SP, Brazil
São Paulo - SP, Brazil
São Paulo - SP, Brazil
Praha 5 - Nove Butovice, Czechia
Copenhagen K, Denmark
Copenhagen NV, Denmark
Farkasgyepü, Hungary
Torrette Di Ancona (Ancona), Italy
Bunkyo-ku, Tokyo, Japan
Kamogawa, Chiba, Japan
Komaki, Aichi, Japan
Kurume, Fukuoka, Japan
Matsumoto, Nagano, Japan
Morioka, Iwate, Japan
Osaka, Osaka, Japan
Osakasayama, Osaka, Japan
Sendai, Miyagi, Japan
Seto, Aichi, Japan
Yokote, Akita, Japan
Guadalajara, Jal., Mexico
Zapopan, Jalisco, Mexico
Leganés, Madrid, Spain
Cottingham, Hull, United Kingdom
Solihull, Birmingham, United Kingdom